The Association of Falling Insulin Requirements With Maternal Biomarkers and Placental Dysfunction: A Prospective Study of Women With Preexisting Diabetes in Pregnancy
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
OBJECTIVE To investigate the association of falling insulin requirements (FIR) among women with preexisting diabetes with adverse obstetric outcomes and maternal biomarkers longitudinally in pregnancy. RESEARCH DESIGN AND METHODS A multicenter prospective cohort study of 158 women (41 with type 1 diabetes and 117 with type 2 diabetes) was conducted. Women with FIR of ≥15% from the peak total daily dose after 20 weeks' gestation were considered case subjects (n = 32). The primary outcome was a composite of clinical markers of placental dysfunction (preeclampsia, small for gestational age [≤5th centile], stillbirth, premature delivery [<30 weeks], and placental abruption). Maternal circulating angiogenic markers (placental growth factor [PlGF] and soluble fms-like tyrosine kinase 1 [sFlt-1]), placental hormones (human placental lactogen, progesterone, and tumor necrosis factor-α), HbA1c, and creatinine were studied serially during pregnancy. RESULTS FIR ≥15% were associated with an increased risk of the composite primary outcome (odds ratio [OR] 4.38 [95% CI 1.9–10.3]; P < 0.001), preeclampsia (OR 6.76 [95% CI 2.7–16.7]; P < 0.001), and was more common among women with type 1 diabetes (36.6 vs. 14.5%; P = 0.002). Creatinine was modestly elevated among women with FIR ≥15%; however, there was no difference in HbA1c. The ratio of sFlt-1 to PlGF was significantly higher among women with FIR at 25, 30, and 36 weeks, with differences maintained in the subgroup that developed preeclampsia. There was no difference in placental hormones between the groups. CONCLUSIONS This is the first prospective study to associate FIR with altered expression of placental antiangiogenic factors and preeclampsia. FIR are an important clinical sign, among women with preexisting diabetes, that should alert the clinician to investigate underlying placental dysfunction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A rapid reduction in insulin requirements can indicate the development of placental insufficiency (32).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [32]
Citations
Cites
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A. C., Sennström, M., Olovsson, M., Brennecke, S. P., Stepan, H., Allegranza, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1414838 · Cited by 1,783
Tranquilli, A. L., Dekker, G., Magee, L., Roberts, J., Sibai, B. M., Steyn, W., Zeeman, G. G., & Brown, M. A. (2014) · Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health · doi:10.1016/j.preghy.2014.02.001 · Cited by 1,417
TNF-α Is a Predictor of Insulin Resistance in Human Pregnancy
Kirwan, J. P., Hauguel-De Mouzon, S., Lepercq, J., Challier, J.-C., Huston-Presley, L., Friedman, J. E., Kalhan, S. C., & Catalano, P. M. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2207 · Cited by 738
Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia
Rana, S., Powe, C. E., Salahuddin, S., Verlohren, S., Perschel, F. H., Levine, R. J., Lim, K.-H., Wenger, J. B., Thadhani, R., & Karumanchi, S. A. (2012) · Circulation · doi:10.1161/circulationaha.111.054361 · Cited by 668
Verlohren, S., Herraiz, I., Lapaire, O., Schlembach, D., Moertl, M., Zeisler, H., Calda, P., Holzgreve, W., Galindo, A., Engels, T., et al. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.07.037 · Cited by 448
Role of Gestational Hormones in the Induction of Insulin Resistance*
RYAN, E. A., & ENNS, L. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-2-341 · Cited by 395
Weissgerber, T. L., & Mudd, L. M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0579-4 · Cited by 357
Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia
Thadhani, R., Hagmann, H., Schaarschmidt, W., Roth, B., Cingoez, T., Karumanchi, S. A., Wenger, J., Lucchesi, K. J., Tamez, H., Lindner, T., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015020157 · Cited by 278
Jovanovic, L., Druzin, M., & Peterson, C. M. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90301-6 · Cited by 268
Akolekar, R., Zaragoza, E., Poon, L. C. Y., Pepes, S., & Nicolaides, K. H. (2008) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.6244 · Cited by 265
Developmental biology of the placenta and the origins of placental insufficiency
Chaddha, V., Viero, S., Huppertz, B., & Kingdom, J. (2004) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2004.03.006 · Cited by 264
Pathophysiology of Fetal Growth Restriction: Implications for Diagnosis and Surveillance
Baschat, A. A. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000133943.54530.76 · Cited by 204
Wikström, A.-K., Larsson, A., Eriksson, U. J., Nash, P., Nordén-Lindeberg, S., & Olovsson, M. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000264552.85436.a1 · Cited by 188
First‐trimester maternal factors and biomarker screening for preeclampsia
Poon, L. C., & Nicolaides, K. H. (2014) · Prenatal Diagnosis · doi:10.1002/pd.4397 · Cited by 170
Angiogenic Factors in Preeclampsia: From Diagnosis to Therapy
Karumanchi, S. A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.06421 · Cited by 163
Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension
Spradley, F. T., Tan, A. Y., Joo, W. S., Daniels, G., Kussie, P., Karumanchi, S. A., & Granger, J. P. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06783 · Cited by 147
Biesenbach, G., Raml, A., Schmekal, B., & Eichbauer‐Sturm, G. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01025.x · Cited by 140
Herraìz, I., Simon, E. D. S., Gómez‐Arriaga, P. I., Martínez-Moratalla, J. M., García-Burguillo, A., Jiménez, E., & Galindo, A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160819009 · Cited by 130
Prenatal predictors of chronic lung disease in very preterm infants
Henderson-Smart, D. J., Hutchinson, J. L., Donoghue, D. A., Evans, N. J., Simpson, J. M., & Wright, I. M. R. (2005) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2005.072264 · Cited by 98
Diagnosis of IUGR: traditional biometry
Platz, E., & Newman, R. (2008) · Seminars in Perinatology · doi:10.1053/j.semperi.2008.02.002 · Cited by 94 · cited 1×
“the International Society for the Study of Hypertension in Pregnancy 2014 criteria [16]), SGA (birth weight#5th percentile [17,18]), preterm delivery (,30 weeks) (19), placental abruption, and stillbirth (.”
BackgroundScreening for Placental Insufficiency in High-risk Pregnancies: Is Earlier Better?
Costa, S., Proctor, L., Dodd, J. M., Toal, M., Okun, N. B., Johnson, J.-A., Windrim, R. C., & Kingdom, J. C. (2008) · Placenta · doi:10.1016/j.placenta.2008.09.004 · Cited by 86
Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women
Yu, Y., Jenkins, A. J., Nankervis, A. J., Hanssen, K. F., Scholz, H., Henriksen, T., Lorentzen, B., Clausen, T., Garg, S. K., Menard, M. K., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1182-x · Cited by 73
Cohen, A., Wenger, J., James-Todd, T. M., Lamparello, B. M., Halprin, E., Serdy, S., Fan, S., Horowitz, G. L., Lim, K.-H., Rana, S., et al. (2013) · Hypertension in Pregnancy · doi:10.3109/10641955.2013.837175 · Cited by 66
Insulin requirements during pregnancy in women with type I diabetes.
Steel, J. M., Johnstone, F. D., Hume, R. F., & Mao, J. (1994) · PubMed · Cited by 62
Pinheiro, C. C., Rayol, P., Gozzani, L., dos Reis, L. M., Zampieri, G., Dias, C. B., & Woronik, V. (2014) · Prenatal Diagnosis · doi:10.1002/pd.4432 · Cited by 54
Alahakoon, T. I., Zhang, W., Trudinger, B., & Lee, V. W. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.880882 · Cited by 53
Self-citationPreeclampsia Pathogenesis: “Triple A Rating”–Autoantibodies and AntiAngiogenic Factors
Karumanchi, S. A., & Lindheimer, M. D. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.100735 · Cited by 51
McManus, R. M., & Ryan, E. A. (1992) · Diabetes Care · doi:10.2337/diacare.15.10.1323 · Cited by 48
Kulozik, F., & Hasslacher, C. (2013) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018813501188 · Cited by 45
Padmanabhan, S., McLean, M., & Cheung, N. W. (2014) · Diabetes Care · doi:10.2337/dc14-0506 · Cited by 36
Self-citationPadmanabhan, S., Jiang, S., McLean, M. P., & Cheung, N. W. (2016) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12446 · Cited by 31
Self-citationStewart, M., Whittaker, P. G., LIND, T., Persson, B., & Hanson, U. (1989) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1989.tb02415.x · Cited by 24
Achong, N., Callaway, L. K., dʼEmden, M. C., McIntyre, D. H., Lust, K. M. C., & Barrett, H. L. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.013 · Cited by 24
Wn, S., & Je, C. (1973) · PubMed · Cited by 19
Management of Maternal Diabetes in Pregnancy
Essex, N., & Pyke, D. A. (1979) · Springer eBooks · doi:10.1007/978-3-642-66972-9_22 · Cited by 7
Cited by
15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s014 · Cited by 381
15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s015 · Cited by 284
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s014 · Cited by 268
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s015 · Cited by 252
Metadata
- Authors
- Padmanabhan, S., Lee, V. W., Mclean, M., Athayde, N., Lanzarone, V., Khoshnow, Q., Peek, M. J., & Cheung, N. W.
- Affiliations
- The University of Sydney (AU)
- Blacktown & Mount Druitt Hospital (AU)
- Westmead Hospital (AU)
- Nepean Hospital (AU)
- Australian National University (AU)
- Corresponding author
- Padmanabhan, Suja
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-08-10
- Volume
- 40
- Issue
- 10
- Pages
- 1323-1330
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2742424235
- Cited by
- 55
- References
- 40
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 7 · 2023: 7 · 2022: 7 · 2021: 11 · 2020: 5 · 2019: 4 · 2018: 2 · 2017: 2
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- type 1 diabetes, type 2 diabetes, placental insufficiency, preeclampsia, angiogenic biomarkers, small for gestational age, stillbirth, placental abruption, human placental lactogen, placental hormones, maternal biomarkers, adverse obstetric outcomes
- MeSH terms
- Adult, Creatinine, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Female, Glycated Hemoglobin, Humans, Infant, Infant, Small for Gestational Age, Insulin, Placenta, Placental Hormones, Pregnancy, Pregnancy Complications, Pregnancy in Diabetics, Pregnancy Outcome, Prospective Studies, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.